HCW Biologics is trading at $3.16 (-5.81%) after the September 2, 2026 news announcement, though the after-hours decline is unexplained.
- It closed at $3.35 on September 2, 2026.
- The news announced a USPTO Notice of Allowance for HCW9302’s alopecia areata use and four additional patents, with encouraging preliminary responses and no dose-limiting toxicities.
- Broader markets were modestly higher, and the release gave no explanation for the after-hours decline.